The Mass Spectrometry metabolomics core has well established methodologies to provide qualitative and quantitative measures of specific metabolites such as amino acids, lipid-related metabolites including ceramides, phosphometabolites, and substrates of the citric acid cycle as well as drug metabolites. These measurements complement our methodologies to measure stable isotope abundance in a variety of molecules including fatty acids, amino acids, carbohydrates, and phosphometabolites. These methodologies in combination with our expertise in multi-compartment modeling offer the opportunity to not only to measure the concentrations of metabolites but also to understand how concentrations are determined by changes in the rate of appearance or disposal of a given analyte. It also allows us to determine the metabolic fates and dynamics of the metabolic network of various metabolic processes between various body compartments. The current facility has 11 different classes of mass spectrometer supported by 9 highly trained technical staff and supports over 50 investigators (40 of whom are NIH-funded). Currently <10% of the services undertaken are provided to investigators outside Mayo Clinic. The mass spectrometry Core is closely integrated to the NMRS core to complement our mutual strengths and is connected closely with the proteomics, genomics and microbiome programs which are all served by a common bioinformatics/bio statistics group. There are multiple requests for access to our facility from investigators from other national centers but only an expanded facility can respond to the increasing demands. In this application we propose the acquisition of three additional mass spectrometers and three additional technical staff so as to expand the analytical capabilities as well as the overall capacity of the core enabling an expansion of the services provided to a larger number of investigators both within and outside of the Mayo Clinic. The existing facilities currently provide assistance to investigators in isotope selection and experimental design as well as bioinformatics and mathematical modeling support thereby enabling the research objectives to be accomplished. The plan is to enable the program to be self-sustaining within a five year period. We have an established prioritization program for sample analysis that was approved by NIH review at the time of our CTSA grant renewal and that program will be extended to meet the requirement of the proposed comprehensive program. Thus the overall goal of this application is to expand the facility enabling us to offer the expertise and services to other national institutions thereby advancing metabolomics-based

Public Health Relevance

This proposal is prepared in response to RFA-RM-11-016: Regional Comprehensive Metabolomics Resource Cores (RCMRC) (U24) and will implement Mass Spectrometry based measures of labeled (by means of stable isotopes) or unlabeled metabolites. These methodologies in combination with our expertise in multi-compartment modeling offer the opportunity to measure the concentrations of metabolites but also their rates of appearance and disposal.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Zabielski, Piotr; Lanza, Ian R; Gopala, Srinivas et al. (2016) Altered Skeletal Muscle Mitochondrial Proteome As the Basis of Disruption of Mitochondrial Function in Diabetic Mice. Diabetes 65:561-73
Kakazu, Eiji; Mauer, Amy S; Yin, Meng et al. (2016) Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner. J Lipid Res 57:233-45
Basu, Ananda; Veettil, Sona; Dyer, Roy et al. (2016) Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study. Diabetes Technol Ther 18 Suppl 2:S243-7
Hinshaw, Ling; Schiavon, Michele; Dadlani, Vikash et al. (2016) Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes. J Clin Endocrinol Metab 101:1954-62
Irving, Brian A; Wood, G Craig; Bennotti, Peter N et al. (2016) Nutrient Transporter Expression in the Jejunum in Relation to Body Mass Index in Patients Undergoing Bariatric Surgery. Nutrients 8:
Vella, Adrian; Jensen, Michael D; Nair, K Sreekumaran (2016) Eulogy for the Metabolic Clinical Investigator? Diabetes 65:2821-3
Kline, Timothy L; Irazabal, Maria V; Ebrahimi, Behzad et al. (2016) Utilizing magnetization transfer imaging to investigate tissue remodeling in a murine model of autosomal dominant polycystic kidney disease. Magn Reson Med 75:1466-73
O'Neill, Brian T; Lee, Kevin Y; Klaus, Katherine et al. (2016) Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis. J Clin Invest 126:3433-46
Johnson, Matthew L; Distelmaier, Klaus; Lanza, Ian R et al. (2016) Mechanism by Which Caloric Restriction Improves Insulin Sensitivity in Sedentary Obese Adults. Diabetes 65:74-84
Savica, Rodolfo; Murray, Melissa E; Persson, Xuan-Mai et al. (2016) Plasma sphingolipid changes with autopsy-confirmed Lewy Body or Alzheimer's pathology. Alzheimers Dement (Amst) 3:43-50

Showing the most recent 10 out of 62 publications